Jon Chung

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study

Andrea Necchi, Andrea Anichini, Daniele Raggi et al. · Journal of Clinical Oncology · 2018 · 712 citations

Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers

Aatur D. Singhi, Ben George, Joel Greenbowe et al. · Gastroenterology · 2019 · 329 citations · Full text

Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies

Andrea Necchi, Daniele Raggi, Andrea Gallina et al. · European Urology · 2019 · 313 citations

Urology, Genitourinary Cancer, Muscle-invasive Bladder Carcinoma +7

Analytical Validation of a Hybrid Capture–Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA

Travis Clark, Jon Chung, Mark Kennedy et al. · Journal of Molecular Diagnostics · 2018 · 191 citations · Full text

Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms

Hanna Tukachinsky, Russell W. Madison, Jon Chung et al. · Clinical Cancer Research · 2021 · 186 citations · Full text